Evidence map›Paper›PMID 40052814›Full record

ReviewLangmuir : the ACS journal of surfaces and colloids2025

Strategies to Enhance Protein Delivery.

Yucheng Zhu, Weisi Zhuang, Hao Cheng

Abstract readReview
In one paragraph

Review in Langmuir : the ACS journal of surfaces and colloids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yucheng ZhuDepartment of Materials Science and Engineering, Drexel University, Philadelphia, Pennsylvania 19104, United States.
Weisi ZhuangDepartment of Materials Science and Engineering, Drexel University, Philadelphia, Pennsylvania 19104, United States.ORCID 0000-0002-3614-6875
Hao ChengDepartment of Materials Science and Engineering, Drexel University, Philadelphia, Pennsylvania 19104, United States.ORCID 0000-0003-3661-1519

Funding

Zwitterionic polyethylene glycol for therapeutic deliveryR01GM155729 · NIGMS · DREXEL UNIVERSITY · PI CHENG, HAO · 2024 to 2025
$637k
Polymer-derived biomaterials for mRNA delivery to induce antigen-specific immune toleranceR56AI177800 · NIAID · DREXEL UNIVERSITY · PI CHENG, HAO · 2023 to 2023
$350k
NIAID NIH HHS R56 AI177800NIGMS NIH HHS R01 GM155729
6 · The paper itself

Abstract

Therapeutic proteins play a crucial role in modern healthcare. However, the rapid clearance of proteins in the circulation system poses a significant threat to their therapeutic efficacy. The generation of anti-drug antibodies expedites drug clearance, resulting in another challenge to overcome in protein delivery. Several methods to increase the circulation half-lives of these proteins and to minimize their immunogenicity have been developed. This Review discusses the causes of protein clearance in the body, evaluates the FDA-approved strategies to prolong protein circulation, and highlights recent progress in the field. Additionally, the strengths and drawbacks of these methods and our perspectives for advancing protein delivery are provided.

Indexed as

Drug Delivery SystemsProteinsAnimalsHumansProteins

Identifiers

PMID40052814
PMCPMC11924232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.